Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present final ...
Rosalind Franklin University announced today that Dr. Joanne Kwak-Kim, director of the university's Reproductive Medicine and ...
Trial initiation in food allergy follows promising results in Phase 2 trial in chronic spontaneous urticaria, another IgE-driven conditionRAPT ...
Ethical and statistical power issues limit the use of randomized controlled trials to study medication and vaccine use during ...
C5aR1 plays an important role in the immune cascade that causes tissue inflammation, particularly in neutrophil-mediated conditions. There’s an obvious overlap with Biogen’s own izastobart, an ...
About RAPT Therapeutics, Inc. RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with ...
Immuron Limited announced the submission of the Clinical Study Report for its Phase 2 clinical trial of Travelan® (IMM-124E) to the FDA, which demonstrated statistically significant immunological and ...
Immunology's transformative impact on global health, from Nobel Prizes to COVID-19 vaccines, underscores its critical role in ...
• Troy Randall – Med – Clinical Immunology and Rheumatology - The epigenetic modifier Kmt2a regulates humoral responses to influenza by orchestrating B cell function in the pre-inducible ...
Thought LeadersLiam O'Mahony, Barry Skillington & John MacSharryProf. of Immunology, Cheif Commerical Officer & Research PartnerAtlantia and Clinical Trials Though most people know that their immune ...
The UAB Division of Clinical Immunology and Rheumatology hosts an annual continuing medical education event for area providers to learn the latest updates in rheumatologic conditions and treatment.
US biotech major Biogen and Chicago, Canada-based Vanqua Bio today announced a license agreement granting Biogen exclusive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback